FLAURA Data & Osimertinib High PFS as Front-Line Agent
Roy S. Herbst, MD, PhD of Yale Cancer Center discusses how the FLAURA data & Osimertinib result in high PFS as front-line agent. From the 22nd Annual Perspectives in Thoracic Oncology in New York http...
Author: thoraciconcology
Added: 01/04/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts